文献
J-GLOBAL ID:201702275972546715
整理番号:17A1378585
JAK2阻害剤CEP 33779とNVP BSK805は高P糖蛋白質阻害活性を有し,ビンクリスチンへの薬剤耐性癌細胞を感作する【Powered by NICT】
The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine
著者 (6件):
Cheon Ji Hyun
(School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea)
,
Kim Kyeong Seok
(School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea)
,
Yadav Dharmendra Kumar
(College of Pharmacy, Gachon University, Incheon 21936, Republic of Korea)
,
Kim Mihyun
(College of Pharmacy, Gachon University, Incheon 21936, Republic of Korea)
,
Kim Hyung Sik
(School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea)
,
Yoon Sungpil
(School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea)
資料名:
Biochemical and Biophysical Research Communications
(Biochemical and Biophysical Research Communications)
巻:
490
号:
4
ページ:
1176-1182
発行年:
2017年
JST資料番号:
B0118A
ISSN:
0006-291X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)